Arterial thrombosis—insidious, unpredictable and deadly

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725

Global status report on noncommunicable diseases 2010.

Alwan, A. (2011) · Cited by 8,494

Inflammation in atherosclerosis

Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503

Inflammation in Atherosclerosis

Libby, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179705 · Cited by 3,736

Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction

DeWood, M. A., Spores, J., Notske, R., Mouser, L. T., Burroughs, R., Golden, M. S., & Lang, H. T. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010163031601 · Cited by 2,740

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

Dennis, M. S. (1996) · The Lancet · Cited by 2,728

Thrombin signalling and protease-activated receptors

Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482

Platelet Activation and Atherothrombosis

Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135

Molecular Bases of the Acute Coronary Syndromes

Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028

Mechanisms of Thrombus Formation

Furie, B., & Furie, B. C. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801082 · Cited by 1,926

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)

Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.015 · Cited by 1,911

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192663 · Cited by 1,700

Platelets in atherothrombosis

Ruggeri, Z. M. (2002) · Nature Medicine · doi:10.1038/nm1102-1227 · Cited by 1,589

Intraplaque Hemorrhage and Progression of Coronary Atheroma

Kolodgie, F. D., Gold, H. K., Burke, A. P., Fowler, D. R., Kruth, H. S., Weber, D. K., Farb, A., Guerrero, L. J., Hayase, M., Kutys, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035655 · Cited by 1,486

Platelets in inflammation and atherogenesis

Gawaz, M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27196 · Cited by 1,468

Identification of the platelet ADP receptor targeted by antithrombotic drugs

Hollopeter, G., Jantzen, H.-M., Vincent, D., Li, G., England, L., Ramakrishnan, V., Yang, R.-B., Nurden, P., Nurden, A., Julius, D., et al. (2001) · Nature · doi:10.1038/35051599 · Cited by 1,423

Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor

Savage, B., Saldívar, E., & Ruggeri, Z. M. (1996) · Cell · doi:10.1016/s0092-8674(00)80983-6 · Cited by 1,196

Platelet-collagen interaction: is GPVI the central receptor?

Nieswandt, B., & Watson, S. P. (2003) · Blood · doi:10.1182/blood-2002-12-3882 · Cited by 1,150

The final steps of integrin activation: the end game

Shattil, S. J., Kim, C., & Ginsberg, M. H. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2871 · Cited by 1,086

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.

Falk, E. (1985) · Circulation · doi:10.1161/01.cir.71.4.699 · Cited by 1,054

Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi.

Falk, E. (1983) · Heart · doi:10.1136/hrt.50.2.127 · Cited by 1,012

Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary Syndromes

Rao, S. V. (2004) · JAMA · doi:10.1001/jama.292.13.1555 · Cited by 1,007

Calcium-dependent phospholipid scrambling by TMEM16F

Suzuki, J., Umeda, M., Sims, P. J., & Nagata, S. (2010) · Nature · doi:10.1038/nature09583 · Cited by 979

Healed Plaque Ruptures and Sudden Coronary Death: Evidence That Subclinical Rupture Has a Role in Plaque Progression

Burke, A. P., Kolodgie, F. D., Farb, A., Weber, D. K., Malcom, G. T., Smialek, J., & Virmani, R. (2001) · Circulation · doi:10.1161/01.cir.103.7.934 · Cited by 919

Clinical features of sudden obstruction of the coronary arteries

HERRICK, J. B. (1912) · Journal of the American Medical Association · doi:10.1001/jama.1912.04270120001001 · Cited by 908

A shear gradient–dependent platelet aggregation mechanism drives thrombus formation

Nesbitt, W. S., Westein, E., Tovar-Lopez, F. J., Tolouei, E., Mitchell, A., Fu, J., Carberry, J., Fouras, A., & Jackson, S. P. (2009) · Nature Medicine · doi:10.1038/nm.1955 · Cited by 862

Exposure of platelet fibrinogen receptors by ADP and epinephrine.

Bennett, J. S., & Vilaire, G. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109597 · Cited by 849

Warfarin, Aspirin, or Both after Myocardial Infarction

Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., & Arnesen, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020496 · Cited by 846

Microparticles in Hemostasis and Thrombosis

Owens, A. P., & Mackman, N. (2011) · Circulation Research · doi:10.1161/circresaha.110.233056 · Cited by 835

Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo

Müller, F., Mutch, N. J., Schenk, W. A., Smith, S. A., Esterl, L., Spronk, H. M., Schmidbauer, S., Gahl, W. A., Morrissey, J. H., & Renné, T. (2009) · Cell · doi:10.1016/j.cell.2009.11.001 · Cited by 831

Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow

Savage, B., Almus-Jacobs, F., & Ruggeri, Z. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81607-4 · Cited by 801

Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2

Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., & FitzGerald, G. A. (2002) · Science · doi:10.1126/science.1068711 · Cited by 789

Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin

Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B. C., & Furie, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021868 · Cited by 752

Antiplatelet Drugs

Patrono, C., Baigent, C., Hirsh, J., & Roth, G. (2008) · Chest · doi:10.1378/chest.08-0672 · Cited by 748

β3-integrin–deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival

Hodivala-Dilke, K. M., McHugh, K. P., Tsakiris, D. A., Rayburn, H., Crowley, D., Ullman-Culleré, M., Ross, F. P., Coller, B. S., Teitelbaum, S., & Hynes, R. O. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5487 · Cited by 740

The growing complexity of platelet aggregation

Jackson, S. P. (2007) · Blood · doi:10.1182/blood-2006-12-027698 · Cited by 737

CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism

André, P., Prasad, K. S. S., Denis, C. V., He, M., Papalia, J. M., Hynes, R. O., Phillips, D. R., & Wagner, D. D. (2002) · Nature Medicine · doi:10.1038/nm0302-247 · Cited by 726

Defective thrombus formation in mice lacking coagulation factor XII

Renné, T., Pozgajová, M., Grüner, S., Schuh, K., Pauer, H.-U., Burfeind, P., Gailani, D., & Nieswandt, B. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050664 · Cited by 683

Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse

Falati, S., Gross, P., Merrill-Skoloff, G., Furie, B. C., & Furie, B. (2002) · Nature Medicine · doi:10.1038/nm782 · Cited by 669

Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic Plaques: A Role for Apoptosis in Plaque Thrombogenicity

Mallat, Z., Hugel, B., Ohan, J., Lesèche, G., Freyssinet, J.-M., & Tedgui, A. (1999) · Circulation · doi:10.1161/01.cir.99.3.348 · Cited by 638

Platelet Hyperreactivity and Prognosis in Survivors of Myocardial Infarction

Trip, M. D., Cats, V. M., van Capelle, F. J. L., & Vreeken, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222201 · Cited by 617

Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques

Toschi, V., Gallo, R., Lettino, M., Fallon, J. T., Gertz, S. D., Ferna´ndez-Ortiz, A., Chesebro, J. H., Badimon, L., Nemerson, Y., Fuster, V., et al. (1997) · Circulation · doi:10.1161/01.cir.95.3.594 · Cited by 603

Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes

Mizuno, K., Satomura, K., Miyamoto, A., Arakawa, K., Shibuya, T., Arai, T., Kurita, A., Nakamura, H., & Ambrose, J. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260502 · Cited by 591

Cell Adhesion Mechanisms in Platelets

Varga-Szabo, D., Pleines, I., & Nieswandt, B. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.150474 · Cited by 588

How the protease thrombin talks to cells

Coughlin, S. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11023 · Cited by 576

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

Sørensen, R., Hansen, M. L., Abildstrom, S. Z., Hvelplund, A., Andersson, C., Jørgensen, C., Madsen, J. K., Hansen, P. R., Køber, L., Torp-Pedersen, C., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61751-7 · Cited by 575

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation

Enjyoji, K., Sévigny, J., Lin, Y., Frenette, P. S., Christie, P. D., Esch, J. S. A., Imai, M., Edelberg, J. M., Rayburn, H., Lech, M., et al. (1999) · Nature Medicine · doi:10.1038/12447 · Cited by 565

Bernard-Soulier Syndrome

López, J. A., Andrews, R. K., Afshar-Kharghan, V., & Berndt, M. C. (1998) · Blood · doi:10.1182/blood.v91.12.4397 · Cited by 560

Fluid Mechanics of Vascular Systems, Diseases, and Thrombosis

Wootton, D. M., & Ku, D. N. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.299 · Cited by 559

Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen

Nieswandt, B. (2001) · The EMBO Journal · doi:10.1093/emboj/20.9.2120 · Cited by 548

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Jernberg, T., Payne, C. D., Winters, K. J., Darstein, C., Brandt, J. T., Jakubowski, J. A., Naganuma, H., Siegbahn, A., & Wallentin, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi877 · Cited by 538

A Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo

Massberg, S., Gawaz, M., Grüner, S., Schulte, V., Konrad, I., Zohlnhöfer, D., Heinzmann, U., & Nieswandt, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20020945 · Cited by 516

Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype

Podrez, E. A., Byzova, T. V., Febbraio, M., Salomon, R. G., Ma, Y., Valiyaveettil, M., Poliakov, E., Sun, M., Finton, P. J., Curtis, B. R., et al. (2007) · Nature Medicine · doi:10.1038/nm1626 · Cited by 513

A mouse model of severe von Willebrand disease: Defects in hemostasis and thrombosis

Denis, C., Methia, N., Frenette, P. S., Rayburn, H., Ullman-Culleré, M., Hynes, R. O., & Wagner, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9524 · Cited by 513

Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen

Ni, H., Denis, C. V., Subbarao, S., Degen, J. L., Sato, T. N., Hynes, R. O., & Wagner, D. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9896 · Cited by 492

Molecular Basis for ADP-induced Platelet Activation

Jin, J., Daniel, J. L., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2030 · Cited by 477

Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion.

EFalk (1985) · Circulation · Cited by 464

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

Kleinschnitz, C., Stoll, G., Bendszus, M., Schuh, K., Pauer, H.-U., Burfeind, P., Renné, C., Gailani, D., Nieswandt, B., & Renné, T. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052458 · Cited by 452

The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen

Poole, A., Gibbins, J. M., Turner, M., van Vugt, M. J., van de Winkel, J. G. J., Saito, T., Tybulewicz, V. L. J., & Watson, S. P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.9.2333 · Cited by 444

Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis

Angelillo-Scherrer, A., de Frutos, P. G., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M. F., Herbert, J.-M., et al. (2001) · Nature Medicine · doi:10.1038/84667 · Cited by 441

Molecular Basis for ADP-induced Platelet Activation

Daniel, J. L., Dangelmaier, C., Jin, J., Ashby, B., Smith, J. B., & Kunapuli, S. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2024 · Cited by 441

Mechanisms of progression in native coronary artery disease: role of healed plaque disruption

Mann, J., & Davies, M. J. (1999) · Heart · doi:10.1136/hrt.82.3.265 · Cited by 430

Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary Syndromes

Roffi, M., Chew, D. P., Mukherjee, D., Bhatt, D. L., White, J. A., Heeschen, C., Hamm, C. W., Moliterno, D. J., Califf, R. M., White, H. D., et al. (2001) · Circulation · doi:10.1161/hc4801.100029 · Cited by 428

Ueber einen neuen Formbestandtheil des Blutes und dessen Rolle bei der Thrombose und der Blutgerinnung: Untersuchungen

Bizzozero, J. (1882) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01931360 · Cited by 420

Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

Rentrop, K. P., Blanke, H., Karsch, K. R., Wiegand, V., Köstering, H., Oster, H., & Leitz, K. H. (1979) · Clinical Cardiology · doi:10.1002/clc.4960020507 · Cited by 413

The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.

Marcus, A. J., Broekman, M. J., Drosopoulos, J. H., Islam, N., Alyonycheva, T. N., Safier, L. B., Hajjar, K. A., Posnett, D. N., Schoenborn, M. A., Schooley, K. A., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119294 · Cited by 412

Antiplatelet therapies for the treatment of cardiovascular disease

Michelson, A. D. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2957 · Cited by 407

Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions

Siess, W., Zangl, K. J., Essler, M., Bauer, M., Brandl, R., Corrinth, C., Bittman, R., Tigyi, G., & Aepfelbacher, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6931 · Cited by 404

A macro and micro view of coronary vascular insult in ischemic heart disease.

Mj, D. (1990) · PubMed · Cited by 403

Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen

Santoro, S. A. (1986) · Cell · doi:10.1016/0092-8674(86)90073-5 · Cited by 395

Bleeding, Blood Transfusion, and Increased Mortality After Percutaneous Coronary Intervention

Doyle, B. J., Rihal, C. S., Gastineau, D. A., & Holmes, D. R. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.073 · Cited by 392

Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface

Esmon, C. T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7615164 · Cited by 377

A revised model of platelet aggregation

Kulkarni, S., Dopheide, S. M., Yap, C. L., Ravanat, C., Freund, M., Mangin, P., Heel, K. A., Street, A., Harper, I. S., Lanza, F., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7569 · Cited by 347

Structure and Function of von Willebrand Factor

Ruggeri, Z. M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615883 · Cited by 332

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency

Salomon, O., Steinberg, D. M., Koren-Morag, N., Tanne, D., & Seligsohn, U. (2008) · Blood · doi:10.1182/blood-2007-10-120139 · Cited by 327

Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function

Schoenwaelder, S. M., Yuan, Y., Josefsson, E. C., White, M. J., Yao, Y., Mason, K. D., O'Reilly, L. A., Henley, K. J., Ono, A., Hsiao, S., et al. (2009) · Blood · doi:10.1182/blood-2009-01-200345 · Cited by 313

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

Becker, R. C., Moliterno, D. J., Jennings, L. K., Pieper, K. S., Pei, J., Niederman, A., Ziada, K. M., Berman, G., Strony, J., Joseph, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60230-0 · Cited by 299

Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes

Falk, E. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90242-7 · Cited by 298

Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe

HACKETT, D., DAVIES, G., & MASERI, A. (1988) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a062449 · Cited by 292

The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion

Kato, K., Kanaji, T., Russell, S., Kunicki, T. J., Furihata, K., Kanaji, S., Marchese, P., Reininger, A., Ruggeri, Z. M., & Ware, J. (2003) · Blood · doi:10.1182/blood-2003-03-0717 · Cited by 282

Collagen synthesis in atherosclerosis: too much and not enough

Rekhter, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00321-6 · Cited by 280

Effects of factor IX or factor XI deficiency on ferric chloride‐induced carotid artery occlusion in mice

WANG, X., CHENG, Q., XU, L., FEUERSTEIN, G. Z., HSU, M., SMITH, P. L., SEIFFERT, D. A., SCHUMACHER, W. A., OGLETREE, M. L., & GAILANI, D. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01236.x · Cited by 278

Integrin α2-Deficient Mice Develop Normally, Are Fertile, but Display Partially Defective Platelet Interaction with Collagen

Holtkötter, O., Nieswandt, B., Smyth, N., Müller, W., Hafner, M., Schulte, V., Krieg, T., & Eckes, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112307200 · Cited by 274

Generation and rescue of a murine model of platelet dysfunction: The Bernard-Soulier syndrome

Ware, J., Russell, S., & Ruggeri, Z. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050582097 · Cited by 268

Platelet Adhesion under Flow

RUGGERI, Z. M. (2009) · Microcirculation · doi:10.1080/10739680802651477 · Cited by 253

Preclinical and Clinical Studies with Selective Reversible Direct P2Y12Antagonists

van Giezen, J. J. J., & Humphries, R. G. (2005) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2005-869525 · Cited by 251

Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation

Braun, A., Varga-Szabo, D., Kleinschnitz, C., Pleines, I., Bender, M., Austinat, M., Bösl, M., Stoll, G., & Nieswandt, B. (2009) · Blood · doi:10.1182/blood-2008-07-171611 · Cited by 248

Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations.

Brown, B. G., Gallery, C. A., Badger, R. S., Kennedy, J. W., Mathey, D., Bolson, E. L., & Dodge, H. T. (1986) · Circulation · doi:10.1161/01.cir.73.4.653 · Cited by 247

Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?

de Boer, O. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00255-7 · Cited by 241

Phospholipid scramblase: An update

Bevers, E. M., & Williamson, P. L. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.020 · Cited by 240

Glycoprotein VI–dependent and –independent pathways of thrombus formation in vivo

Dubois, C., Panicot-Dubois, L., Merrill-Skoloff, G., Furie, B., & Furie, B. C. (2006) · Blood · doi:10.1182/blood-2005-09-3687 · Cited by 236

Local Inhibition of Tissue Factor Reduces the Thrombogenicity of Disrupted Human Atherosclerotic Plaques: Effects of Tissue Factor Pathway Inhibitor on Plaque Thrombogenicity Under Flow Conditions

Badimon, J. J., Lettino, M., Toschi, V., Fuster, V., Berrozpe, M., Chesebro, J. H., & Badimon, L. (1999) · Circulation · doi:10.1161/01.cir.99.14.1780 · Cited by 228

Cell signalling through thromboxane A2 receptors

Huang, J. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2003.10.008 · Cited by 227

Plasma fibronectin promotes thrombus growth and stability in injured arterioles

Ni, H., Yuen, P. S. T., Papalia, J. M., Trevithick, J. E., Sakai, T., Fässler, R., Hynes, R. O., & Wagner, D. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2628067100 · Cited by 224

The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite

SUGIDACHI, A., OGAWA, T., KURIHARA, A., HAGIHARA, K., JAKUBOWSKI, J. A., HASHIMOTO, M., NIITSU, Y., & ASAI, F. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02598.x · Cited by 220

A Role of the Fast ATP-gated P2X1 Cation Channel in Thrombosis of Small Arteries In Vivo

Hechler, B., Lenain, N., Marchese, P., Vial, C., Heim, V., Freund, M., Cazenave, J.-P., Cattaneo, M., Ruggeri, Z. M., Evans, R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030144 · Cited by 220

Blood rheology in arterial disease

Lowe, G. D. O. (1986) · Clinical Science · doi:10.1042/cs0710137 · Cited by 214

Shear-induced platelet aggregation

O'Brien, J. R. (1990) · The Lancet · doi:10.1016/0140-6736(90)90815-m · Cited by 212

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk

Zhang, H., Löwenberg, E. C., Crosby, J. R., MacLeod, A. R., Zhao, C., Gao, D., Black, C., Revenko, A. S., Meijers, J. C. M., Stroes, E. S., et al. (2010) · Blood · doi:10.1182/blood-2010-04-277798 · Cited by 203

Impaired αIIbβ3Integrin Activation and Shear-Dependent Thrombus Formation in Mice Lacking Phospholipase D1

Elvers, M., Stegner, D., Hagedorn, I., Kleinschnitz, C., Braun, A., Kuijpers, M. E. J., Boesl, M., Chen, Q., Heemskerk, J. W. M., Stoll, G., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000551 · Cited by 193

Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury

Zhu, L., Bergmeier, W., Wu, J., Jiang, H., Stalker, T. J., Cieslak, M., Fan, R., Boumsell, L., Kumanogoh, A., Kikutani, H., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606344104 · Cited by 188

Factor XIIa Inhibitor Recombinant Human Albumin Infestin-4 Abolishes Occlusive Arterial Thrombus Formation Without Affecting Bleeding

Hagedorn, I., Schmidbauer, S., Pleines, I., Kleinschnitz, C., Kronthaler, U., Stoll, G., Dickneite, G., & Nieswandt, B. (2010) · Circulation · doi:10.1161/circulationaha.109.924761 · Cited by 186

[Intracoronary administration of fibrinolysin in acute myocardial infarct].

Chazov, E. I., Ls, M., Mazaev, A. V., Sargin, K. E., Gv, S., & Ruda, M. (1976) · PubMed · Cited by 181

Isolated deficiency of platelet procoagulant activity

Weiss, H. J., Vicic, W. J., Lages, B. A., & Rogers, J. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90392-9 · Cited by 176

Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain

Pinsky, D. J., Broekman, M. J., Peschon, J. J., Stocking, K. L., Fujita, T., Ramasamy, R., Connolly, E. S., Huang, J., Kiss, S., Zhang, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci10649 · Cited by 176

Procoagulant platelets: are they necrotic?

Jackson, S. P., & Schoenwaelder, S. M. (2010) · Blood · doi:10.1182/blood-2010-01-261669 · Cited by 169

Platelet CD36 mediates interactions with endothelial cell–derived microparticles and contributes to thrombosis in mice

Ghosh, A., Li, W., Febbraio, M., Espinola, R. G., McCrae, K. R., Cockrell, E., & Silverstein, R. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34904 · Cited by 169

Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development

Gross, P. L., Furie, B. C., Merrill‐Skoloff, G., Chou, J., & Furie, B. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0405193 · Cited by 166

Process of Progression of Coronary Artery Lesions From Mild or Moderate Stenosis to Moderate or Severe Stenosis: A Study Based on Four Serial Coronary Arteriograms per Year

Yokoya, K., Takatsu, H., Suzuki, T., Hosokawa, H., Ojio, S., Matsubara, T., Tanaka, T., Watanabe, S., Morita, N., Nishigaki, K., et al. (1999) · Circulation · doi:10.1161/01.cir.100.9.903 · Cited by 160

Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate

Siess, W. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00173-7 · Cited by 155

Anti-GPVI–associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRγ-chain complex from the human platelet surface

Boylan, B., Chen, H., Rathore, V., Paddock, C. M., Salacz, M. E., Friedman, K. D., Curtis, B. R., Stapleton, M. A., Newman, D. K., Kahn, M. L., et al. (2004) · Blood · doi:10.1182/blood-2004-03-0896 · Cited by 155

Deletion of the p110β isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo

Martin, V., Guillermet‐Guibert, J., Chicanne, G., Cabou, C., Jandrot‐Perrus, M., Plantavid, M. M., Vanhaesebroeck, B., Payrastre, B., & Gratacap, M. (2010) · Blood · doi:10.1182/blood-2009-04-217224 · Cited by 154

Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRγ deficiency

Mangin, P., Yap, C. L., Nonne, C., Sturgeon, S. A., Goncalves, I., Yuan, Y., Schoenwaelder, S. M., Wright, C. E., Lanza, F., & Jackson, S. P. (2006) · Blood · doi:10.1182/blood-2005-10-4244 · Cited by 152

Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency

Arai, M., Yamamoto, N., Moroi, M., Akamatsu, N., Fukutake, K., & Tanoue, K. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb08900.x · Cited by 152

THE AMERICAN SOCIETY OF HEMATOLOGY

Alexander, W. (2009) · Blood · doi:10.1182/blood.v114.22.r23.r23 · Cited by 146

Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease

Goto, S., Ogawa, H., Takeuchi, M., Flather, M. D., Bhatt, D. L., & on behalf of the J-LANCELOT (Japanese-Lesson from Antagonizing the Cellular Effect of Thrombin) Investigators (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq320 · Cited by 146

Platelet Secretory Mechanisms

Reed, G. L. (2004) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2004-833479 · Cited by 141

The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times

Bruschke, A. V. G., Kramer, J. R., Bal, E. T., Haque, I. U., Detrano, R., & Goormastic, M. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90772-2 · Cited by 141

Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets.

Mailhac, A. C., Badimón, J. J., Fallon, J. T., Fernández‐Ortíz, A., Meyer, B., Chesebro, J. H., Fuster, V., & Badimón, L. (1994) · Circulation · doi:10.1161/01.cir.90.2.988 · Cited by 137

R93W mutation in Orai1 causes impaired calcium influx in platelets

Bergmeier, W., Oh‐hora, M., McCarl, C., Roden, R. C., Bray, P. F., & Feske, S. (2008) · Blood · doi:10.1182/blood-2008-08-174516 · Cited by 132

Nitric oxide signalling in the regulation of cardiovascular and platelet function

Gkaliagkousi, Ε., & Ferro, A. (2010) · Frontiers in bioscience · doi:10.2741/3828 · Cited by 129

The contributions of the α2β1 integrin to vascular thrombosis in vivo

He, L., Pappan, L. K., Grenache, D. G., Li, Z., Tollefsen, D. M., Santoro, S. A., & Zutter, M. M. (2003) · Blood · doi:10.1182/blood-2003-04-1323 · Cited by 125

Platelet Adhesion Receptors and Their Ligands in Mouse Models of Thrombosis

Denis, C. V., & Wagner, D. D. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000259359.52265.62 · Cited by 123

Variable protection of β3-integrin–deficient mice from thrombosis initiated by different mechanisms

Smyth, S. S., Reis, E. D., Väänänen, H., Zhang, W., & Coller, B. S. (2001) · Blood · doi:10.1182/blood.v98.4.1055 · Cited by 117

Complementary roles of platelets and coagulation in thrombus formation on plaques acutely ruptured by targeted ultrasound treatment: a novel intravital model

Kuijpers, M. J. E., Gilio, K., Reitsma, S., Nergiz‐Unal, R., Prinzen, L., Heeneman, S., Lutgens, E., van Zandvoort, M. A. M. J., Nieswandt, B., Egbrink, M. G. A. O., et al. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03186.x · Cited by 113

Anti–Glycoprotein VI Treatment Severely Compromises Hemostasis in Mice With Reduced α 2 β 1 Levels or Concomitant Aspirin Therapy

Grüner, S., Prostredná, M., Aktas, B., et al. (2004) · Circulation · doi:10.1161/01.cir.0000146341.63677.3c · Cited by 110

Thrombasthenic mice generated by replacement of the integrin αIIb gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment

Roux, D. T., Roullot, V., Poujol, C., Kortulewski, T., Nurden, P., & Marguerie, G. A. (2000) · Blood · doi:10.1182/blood.v96.4.1399 · Cited by 108

Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling

Nanda, N., André, P., Bao, M., Clauser, K. R., DeGuzman, F. R., Howie, D., Conley, P. B., Terhorst, C., & Phillips, D. R. (2005) · Blood · doi:10.1182/blood-2005-01-0333 · Cited by 107

The evolution of antiplatelet therapy in cardiovascular disease

Yousuf, O. K., & Bhatt, D. L. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.96 · Cited by 105

New insights into the haemostatic function of platelets

Wei, A. H., Schoenwaelder, S. M., Andrews, R. K., & Jackson, S. P. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07819.x · Cited by 94

The Elegant Platelet: Signals Controlling Actin Assembly

Barkalow, K., Azim, A., Italiano, J., et al. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615858 · Cited by 94

The relation of coronary thrombosis to ischaemic myocardial necrosis

Davies, M. J., Fulton, W. F. M., & Robertson, W. B. (1979) · The Journal of Pathology · doi:10.1002/path.1711270208 · Cited by 89

Changes in cardiovascular risk profile during the cessation of smoking

Terres, W., Becker, P. B., & Rosenberg, A. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90007-8 · Cited by 87

Genetic deletion of mouse platelet glycoprotein Ibβ produces a Bernard-Soulier phenotype with increased α-granule size

Kato, K., Martínez, C., Russell, S., Nurden, P., Nurden, A. T., Fiering, S., & Ware, J. L. (2004) · Blood · doi:10.1182/blood-2004-03-1127 · Cited by 85

Hyperreactive Platelets and Complications of Coronary Artery Disease

Hirsh, J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706113162410 · Cited by 78

Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia

Ma, Y., Ashraf, M. Z., & Podrez, E. A. (2010) · Blood · doi:10.1182/blood-2010-02-268508 · Cited by 76

Platelets in atherothrombosis: lessons from mouse models

Nieswandt, B., Aktas, B., Moers, A., & Sachs, U. J. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01488.x · Cited by 76

Decreased Plasma Fibronectin Leads to Delayed Thrombus Growth in Injured Arterioles

Matuskova, J., Chauhan, A. K., Cambien, B., Astrof, S., Dole, V. S., Piffath, C. L., Hynes, R. O., & Wagner, D. D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000216282.58291.c6 · Cited by 62

LRP and PDGF Signaling: A Pathway to Atherosclerosis

Boucher, P. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.12.001 · Cited by 59

Arrestin-2 Differentially Regulates PAR4 and ADP Receptor Signaling in Platelets

Li, D., D'Angelo, L., Chavez, M., & Woulfe, D. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118018 · Cited by 54

Increased number of high sensitive platelets in hypercholesterolemia, cardiovascular diseases, and after incubation with cholesterol

Opper, C., Clement, C., Schwarz, H., Krappe, J., Steinmetz, A., Schneider, J. E., & Wesemann, W. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05448-r · Cited by 53

What Makes Platelets Angry

Bhatt, D. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.06.027 · Cited by 51

Daily administration of the TP receptor antagonist terutroban improved endothelial function in high‐cardiovascular‐risk patients with atherosclerosis

Lesault, P., Boyer, L., Pelle, G., Covali‐Noroc, A., Rideau, D., Akakpo, S., Teíger, E., Dubois‐Randé, J., & Adnot, S. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03858.x · Cited by 42

Age, cardiovascular risk factors and coronary heart disease as determinants of platelet function in men. A multivariate approach

Terres, W., Weber, K., Kupper, W., & Bleifeld, W. (1991) · Thrombosis Research · doi:10.1016/0049-3848(91)90369-8 · Cited by 40

The epinephrine-blood platelet connection with special reference to essential hypertension

Kjeldsen, S. E., Rostrup, M., Gjesdal, K., et al. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90843-7 · Cited by 19

The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality

Sobieraj‐Teague, M., Gallus, A. S., & Eikelboom, J. W. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283021c5b · Cited by 18

Platelet aggregation and thrombus formation in diabetes mellitus: An in vitro study

Rathbone, R. L. K., Ardlie, N. G., & Schwartz, C. J. (1970) · Pathology · doi:10.3109/00313027009077146 · Cited by 12

The Perils of Combination Antithrombotic Therapy and Potential Resolutions

Fisher, M., & Loscalzo, J. (2011) · Circulation · doi:10.1161/cir.0b013e31820841ce · Cited by 10

Thrombosis as an intravascular effector of innate immunity

Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989

Platelet biology and functions: new concepts and clinical perspectives

van der Meijden, P. E. J., & Heemskerk, J. W. M. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0110-0 · Cited by 1,041

Interplay between inflammation and thrombosis in cardiovascular pathology

Stark, K., & Massberg, S. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00552-1 · Cited by 1,033

Vascular endothelium – Gatekeeper of vessel health

Cahill, P. A., & Redmond, E. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.007 · Cited by 518

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Malehmir, M., Pfister, D., Gallage, S., Szydlowska, M., Inverso, D., Kotsiliti, E., Leone, V., Peiseler, M., Surewaard, B. G. J., Rath, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0379-5 · Cited by 398